欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号AT/H/0150/004
药品名称Hydal uno retard 32 mg - Kapseln
活性成分
    • hydromorphone hydrochloride 32.0 mg
剂型Prolonged release capsule*
上市许可持有人Mundipharma GesmbH Apollogasse 16-18 A-1072 Wien
参考成员国 - 产品名称Austria (AT)
Hydal Uno retard 32 mg - Kapseln
互认成员国 - 产品名称
    • Portugal (PT)
    • Norway (NO)
    • Poland (PL)
    • Estonia (EE)
      Palladone-XL
    • Hungary (HU)
      Palladone-XL 32 mg retard kapszula
    • Slovenia (SI)
许可日期2005/07/06
最近更新日期2020/02/07
药物ATC编码
    • N02AA03 hydromorphone
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Full Dossier [Article 8.3(i)]
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase